A1.
Characteristics of the 10 lung cancer patients
| Patient no. | Diagnosis | CTV (including GTV and mediastinal lymph node regions) | GTV(cm3) | Total dose/dose per fraction/number of fractions | No. of CBCT before regulation | No. of CBCT after irradiation |
|---|---|---|---|---|---|---|
| 1 | Right upper lobe adenocarcinoma post operation and chemotherapy right pulmonary hilar metastasis lymph nodes | 10R | 9.64 | 60 Gy/3 Gy/20f | 11 | 10 |
| 2 | Right upper lobe squamous carcinoma | GTV, 2R, 4R, 7, 10R | 20.55 | 66 Gy/2 Gy/33f | 7 | 7 |
| 3 | Right upper lobe squamous carcinoma superior vena cava syndrome | GTV, 2R, 4, 5, 10R | 62.45 | 66 Gy/2 Gy/33f | 9 | 9 |
| 4 | Right lower lobe NSCLC | GTV, 7, 10R | 81.08 | 60 Gy/2 Gy/30f | 7 | 7 |
| 5 | Right upper lobe cancer | GTV | 21.97 | 60 Gy/6 Gy/10f | 10 | 9 |
| 6 | Left upper lobe squamous carcinoma | GTV, 4L, 5, 6, 7, 10L | 140.76 | 58 Gy/2 Gy/29f | 4 | 4 |
| 7 | Right lobe SCLC post operation and chemotherapy metastasis mediastinal lymph nodes | 4R, 7 | 5.28 | 60 Gy/2 Gy/30f | 9 | 9 |
| 8 | Left lower lobe squamous carcinoma post chemotherapy | GTV, 2, 4, 7, 10L | 44.23 | 60 Gy/2 Gy/30f | 4 | 4 |
| 9 | Left upper lobe SCLC post chemotherapy lung metastasis | GTV, 6, 5, 10L | 88.58 | 37.5 Gy/2.5 Gy/15f | 5 | 4 |
| 10 | Right lower lobe squamous carcinoma | GTV, 7, 10R | 81.15 | 60 Gy/2 Gy/30f | 7 | 7 |
CTV, clinical target volume; GTV, gross tumour volume; NSCLC, non-small cell lung carcinoma; SCLC, small cell lung carcinoma; R, right; L, left; Gy, Gray; f, fractions; CBCT, cone beam computed tomography.